Since the first conference, held in Chicago in December of 1946, these meetings sponsored by the Streptomycin Committee of the Veterans Administration have been increasingly important in presenting the results of a unique and enormous project on the chemotherapy of tuberculosis. The main topics discussed at the eighth conference have been summarized in a report to the Council on Pharmacy and Chemistry (J. A. M. A.142: 650 [March 4] 1950), and these minutes supply the detailed data on which this report was based.
Not only is the use of streptomycin in tuberculosis discussed, but the results of studies with other antibiotics such as aureomycin and neomycin, as well as reports on para-aminosalicylic acid (PAS) and amithiozone (4-acetylaminobenzaldehyde, thiosemicarbazone), formerly TB-1, are presented. To anyone working in the laboratory or on clinical aspects of tuberculosis, the minutes of these streptomycin conferences will be invaluable sources of detailed information unobtainable from